Special Issue "Multi-Omics Approach to COVID-19"
A special issue of COVID (ISSN 2673-8112).
Deadline for manuscript submissions: 30 June 2023 | Viewed by 1320
Special Issue Editor
Interests: COVID-19; T cells; metabolomics; transcriptomics; genomics; machine learning
Special Issue Information
Dear Colleagues,
It has been more than 2 years since the COVID-19 pandemic began; however, infection continues despite the COVID-19 vaccines that have been developed. Due to the mutation in spike protein of the SARS-CoV-2 virus, and the waning immunity that occurs 6–8 months post-vaccination, we are still liable to become infected with the virus and develop COVID-19 even after prior infection. The effect of long-term COVID-19 syndrome (LTCS) throughout the world is devastating, and there is still a knowledge gap regarding how our immune system is affected after virus infection. Therefore, understanding the mechanism the virus, and how it leads to LTCS, should be addressed by modulating the different functions of immune cells using multi-omics tools (genomic, transcriptomic, proteomic, metabolomic, and lipidomic, etc.). Thus, we invite you to submit any original research article, review, or commentary to the COVID journal detailing your exciting and cutting-edge data on COVID-19-related research on patients, animal models, or in vitro model systems which include multi-omics tools.
Dr. Yogesh Singh
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. COVID is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- COVID-19
- immune cells (innate and adaptive)
- NK cells
- MAIT
- metabolites
- transcriptomics
- RNA-seq
- protein
- 1H-NMR
- genes
- inflammation
